News

conference

Apr 27, 2025

2025 - AACR

Shasqi presented 2 posters at the 2025 American Association for Cancer Research (AACR) Annual Meeting

conference

Apr 27, 2025

2025 - AACR

First-in-class Click Chemistry-Based Pre-Targeting of CEACAM5 Tumor Antigen Selectively Activates an MMAE Payload at Tumors

conference

Mar 5, 2025

2025 - World ADC London

CEACAM5 is an Ideal Target for Click Chemistry Enabled Pre-Targeting

media

Jan 23, 2025

Drug Discovery Trends

At JPM, Shasqi highlights how click chemistry can tackles ADC’s ‘1% problem’

press

Jan 8, 2025

press release

Shasqi to present at 43rd Annual J.P. Morgan healthcare Conference

conference

Nov 9, 2024

2024 SITC

Attenuated MMAE therapeutic activated by click chemistry at the tumor evokes potent immune responses

conference

Nov 9, 2024

2024 - SITC

Doxorubicin-based click chemistry therapeutic activates potent cytotoxic immune responses in advanced sarcoma patients in a Phase 1/2a clinical trial

conference

Nov 4, 2024

2024 World ADC

CEACAM5 is an Ideal Target for Click Chemistry Enabled Pre-Targeting

conference

Nov 4, 2024

2024 World ADC

Pre-targeting with in vivo Click Chemistry Enables Preferential Drug Exposure in Tumors versus Normal Tissues

press

Oct 31, 2024

press release

Shasqi to present at World ADC and SITC conferences

conference

Oct 23, 2024

2024 - EORTC-NCI-AACR Symposium

Pre-Targeting with in vivo Click Chemistry Enables Preferential Drug Exposure in Tumors versus Normal Tissues

conference

Oct 10, 2024

2024 - SITC

Shasqi announces two abstracts accepted for poster presentation at the SITC 39th Annual Meeting, held November 8-10, 2024, in Houston, TX